BIO-RAD LABORATORIES-A (BIO) Institutional Ownership

BIO is currently held by 5 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.06B based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is First Eagle U.S. Value, which reported ownership valued at approximately $725.52M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, First Eagle U.S. Value's BIO position is now estimated to be worth approximately $740.93M, representing an estimated gain of +2.12% since the filing period.

Major shareholders tracked on this page include First Eagle U.S. Value, Ariel Appreciation Fund, Parnassus Endeavor Fund, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward BIO-RAD LABORATORIES-A (BIO).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20265$1,061,087,5603,806,592
Q4 20254$1,155,881,2433,814,915
Q3 20254$1,088,580,8523,882,381
Q2 20254$957,664,0433,968,440
Q1 20254$714,304,5592,932,766
Q4 20244$621,989,3351,893,365
Q3 20244$575,732,8841,720,763
Q2 20245$376,178,1641,377,387
Q1 20245$224,402,447649,561
Q4 20236$196,199,529608,452
Q3 20234$197,821,385551,880
Q2 20236$125,473,879332,812